| Followers | 198 |
| Posts | 13482 |
| Boards Moderated | 0 |
| Alias Born | 06/20/2022 |
Wednesday, February 21, 2024 9:56:04 AM
Recent EVGN News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:27:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:24:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:06:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:03:42 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 12:00:07 PM
- Evogene Reports Fourth Quarter and Full Year 2025 Financial Results • PR Newswire (US) • 03/05/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/25/2026 01:00:32 PM
- Evogene Releases CEO Letter to Shareholders • PR Newswire (US) • 02/25/2026 01:00:00 PM
- Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/11/2026 09:00:13 PM
- Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases • PR Newswire (US) • 02/11/2026 01:00:00 PM
- Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds • PR Newswire (US) • 02/10/2026 06:20:00 PM
- Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer • GlobeNewswire Inc. • 02/05/2026 03:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 01:00:09 PM
- Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer • PR Newswire (US) • 02/04/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/15/2026 09:00:11 PM
- Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders • PR Newswire (US) • 01/07/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 12:00:06 PM
- Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development • PR Newswire (US) • 12/30/2025 12:00:00 PM
- Evogene shares climb 5% as cost reductions help deliver earnings beat • IH Market News • 11/20/2025 03:08:26 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 12:00:22 PM
- Evogene Reports Third Quarter 2025 Financial Results • PR Newswire (US) • 11/20/2025 12:00:00 PM
- Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming • PR Newswire (US) • 11/11/2025 12:00:00 PM
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
